Receive the latest updates from Matrix Medical in real time to understand product information.

The clinical follow-up for the first phase of the NVS series "coronary vascular remodeling catheter" has been completed

The implementation of the project "Research on the Technology and Management Mode of Early Coronary Intervention without Implantation Therapy" will greatly improve the treatment effectiveness and rehabilitation prospects of early coronary heart disease patients, with the goal of providing customized precision intervention therapy and non implantation therapy strategies for early coronary heart disease patients in China. This action not only accelerated the realization process of the grand goal of "Healthy China 2030", but also marked that China is expected to achieve a historic change in reducing the incidence rate and mortality of early coronary heart disease, opening a new chapter for the health and well-being of the people.

 About Matrix

Future oriented innovation intervention technology platform

Hangzhou Matrix Medical Technology Co., Ltd. (hereinafter referred to as' Juzheng Medical ') was founded in 2021 and is the first high-tech enterprise in China to master intravascular photochemical cross-linking technology. It focuses on the research and development and production of innovative medical devices in the field of vascular intervention, and is committed to the research and development of a series of natural vascular stent products without implantation. Juzheng Medical is headquartered in Hangzhou Future Science and Technology City and has a production base of 1700 square meters in Anji.

In the future, MatrixMedical will continue to adhere to the concept of "intervention without implantation", develop new interventional medical devices, take solving clinical pain points as the first starting point, truly provide new solutions for patients undergoing vascular intervention therapy, and actively promote the research and development of innovative technologies to further promote the development of the field of vascular intervention therapy.